Skip to main content
OpenTrials
Completed

NCT Number: NCT02709759

Behavioral Interventions to Reduce Heavy Drinking Among MSM in HIV Primary Care

The purpose of the present study is to conduct a fully-crossed 2 X 2 X 2 factorial randomized controlled trial with a diverse sample of 224 MSM recruited from 2 urban HIV primary care clinics (one in the Northeast and one in the South). The first study factor will compare brief advice (BA) vs. a motivational intervention (MI) that contains detailed personalized normative and HIV-specific feedback. The second factor compares an interactive text messaging (ITM) intervention vs. no text messaging. The final factor compares intervention of low intensity and duration (two sessions over 1 month) to extended intervention (EI) entailing 5 sessions over 9 months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Fenway Health, Boston, Massachusetts, United States

Loading trial locations.

About this study

Heavy drinking in HIV-infected patients can lead to low antiretroviral therapy adherence and poor virologic control, greater sexual risk taking, increased risk of liver disease, and decreased cognitive function. Therefore, reductions in drinking may have particularly positive and widespread effects in HIV-infected patients. Men who have sex with men (MSM) continue to represent the majority of new HIV infections, and HIV-infected MSM have rates of hazardous drinking as high as 33%. Therefore, developing and testing interventions to reduce heavy drinking in HIV-infected MSM is a very high public health priority. There have been relatively few alcohol interventions tested that focus on MSM, and only two have addressed drinking in HIV-infected MSM. Although recent studies indicate that behavioral interventions can reduce heavy drinking in HIV-infected patients, much remains unknown about the efficacy of different approaches to behavioral intervention and their unique and combined effects. The purpose of the present study is to conduct a fully-crossed 2 X 2 X 2 factorial randomized controlled trial with a diverse sample of 224 MSM recruited from 2 urban HIV primary care clinics (one in the Northeast and one in the South). The first study factor will compare brief advice (BA) vs. a motivational intervention (MI) that contains detailed personalized normative and HIV-specific feedback. The second factor compares an interactive text messaging (ITM) intervention vs. no text messaging. The final factor compares intervention of low intensity and duration (two sessions over 1 month) to extended intervention (EI) entailing 5 sessions over 9 months. BA and MI will be delivered by a core set of interventionists from a central location using a webcam-enabled telemedicine system, which can facilitate larger-scale implementation. The design will allow us to test the hypothesis that MI compared to BA, ITM compared to no ITM, and EI compared to no EI, will result in significantly greater reductions in number of alcoholic drinks consumed and number of heavy drinking days at 6- and 12-month follow-ups. Secondary outcomes include engagement in unprotected anal intercourse, ART adherence and viral suppression, CD4 cell count, liver function tests, and neurocognitive function. We also will test the hypothesis that the effects of MI, ITM, and EI on drinking will be moderated by alcohol use disorder status and readiness to change drinking such that these interventions will be relatively more efficacious in those with a current disorder and those with low readiness. The study will provide crucial evidence regarding which intervention approaches, alone or in combination, are likely to be most efficient to implement on a large scale in HIV care settings.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • be at least 18 years of age
  • drink heavily at least once per month on average (≥5 drinks) or drink have drunk more than 14 drinks per week over the past 3 months
  • have a confirmed diagnosis of HIV
  • be a biological male who identifies as male
  • report having had sex (oral or anal) with a male partner in the past 12 months and/or, identify as gay or bisexual.
  • For those on ART, they must be stabilized on their current regimen for at least 3 months prior to study enrollment.

Exclusion criteria

  • report past 3 month intravenous drug use
  • are currently psychotic, suicidal, or manic
  • being treated or have been treated in the past 3 months for an HIV-related opportunistic infection
  • currently receiving treatment for an alcohol or drug problem.

Treatment and study plan

Motivational Intervention

Behavioral

Involves 60 minutes of counseling delivered by videoconferencing. Provides feedback on drinking and HIV and related behaviors.

Brief Advice

Behavioral

Involves 5-10 minutes of brief counseling to reduce drinking

Interactive text messaging

Behavioral

Involves receiving daily text messages that enable participants to track their drinking and related consequences. Provides feedback on drinking and allow setting of goals.

Primary outcomes

  1. Average Number of Drinks Per Week at 6 Months

    Time frame: Past 30 days

    Average number of alcoholic drinks consumed per week assessed at 6 months. Covers the period of 30 days prior to the assessment.

  2. Average Number of Alcoholic Drinks Consumed Per Week Assessed at 12 Months

    Time frame: Past 30 days

    Average number of alcoholic drinks consumed per week assessed at 12 months. Covers the period of 30 days prior to the assessment.

  3. Number of Heavy Drinking Days at 6 Months

    Time frame: Past 30 days

    Number of heavy drinking days (5 or more alcoholic drinks in a single day) assessed at 6 months

  4. Number of Heavy Drinking Days at 12 Months

    Time frame: Past 30 days

    Number of days drinking 5 or more alcoholic drinks

Sponsors and collaborators

Lead sponsor

Brown University

Other

Registry information

Important dates

Study start
2016
Primary completion
2021
Study completion
2022
First posted
Mar 16, 2016
Registry last updated
Aug 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.